Saol Therapeutics hit with CRL for rare genetic disease
The U.S. FDA issued a complete response letter (CRL) for the NDA to privately held Saol Therapeutics Inc.’s…
Ionis gets approval for preventing attacks in rare and genetic HAE
In Ionis Pharmaceuticals Inc.’s second U.S. FDA approval in under a year, the agency approved Dawnzera (donidalorsen) as…
UK’s MHRA seeks feedback on in-house device manufacturing
In a regulatory round-up, the U.K. Medicines and Healthcare Products Regulatory Agency opened a survey regarding in-house device…
Warning for UK pharmacies supplying scripts overseas – Chemist+Druggist
Warning for UK pharmacies supplying scripts overseas Chemist+DruggistKeep an eye on staff theft, GPhC warns superintendents Pharmacy MagazinePharmacy regulator issues…